• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH PATHROMTIN SL (RILIBAK)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH PATHROMTIN SL (RILIBAK) Back to Search Results
Model Number SEE H10
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/05/2022
Event Type  malfunction  
Manufacturer Narrative
An outside of the united states (ous) customer contacted a siemens customer care center (ccc).Quality controls (qc) recovered in range and no instrument or application issue was identified.The pathromtin sl instructions for use (ifu) indicates "pathromtin sl must be gently inverted (5 to 8 times) to mix before first use".Sedimentation of the pathromtin sl reagent cannot be ruled out as a potential cause of the event.The cause of the event is unknown.The reagent is performing according to specifications.No further evaluation of this device is required.The pathromtin sl (rilibak) reagent is not marketed in the united states (us).This mdr is filed for the us similar reagent (pathromtin sl reagent).The pathromtin sl reagent marketed in the us has catalog number: 10446066, unique device identifier (b)(4), and the pma/510(k) k955450.
 
Event Description
Two falsely elevated activated partial thromboplastin time (aptt) results were obtained on two patient samples on a sysmex cs-5100 system using pathromtim sl (rilibak) reagent.The discordant results were not reported to the physician(s).The sample from patient 1 was repeated for aptt using a new reagent vial on the same system, and the sample from patient 2 was repeated for aptt using an alternate sysmex cs-5100 system.The repeat aptt results for both patients recovered lower.The repeat results were reported, as the correct results, to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the elevated aptt results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PATHROMTIN SL (RILIBAK)
Type of Device
PATHROMTIN SL (RILIBAK)
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
emil-von-behring- str. 76
marburg, D-350 41
GM  D-35041
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
emil-von-behring-str. 76
marburg, D-350 41
GM   D-35041
Manufacturer Contact
christopher aebig
511 benedict ave.
tarrytown, NY 10591
9144153450
MDR Report Key16095513
MDR Text Key308534260
Report Number9610806-2023-00001
Device Sequence Number1
Product Code GFO
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/04/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberSEE H10
Device Catalogue NumberSEE H10
Device Lot NumberSEE H10
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/08/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-